Elliptic Laboratories Revenue vs. Current Valuation
| ELABS Stock | NOK 9.32 0.15 1.58% |
For Elliptic Laboratories profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Elliptic Laboratories to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Elliptic Laboratories AS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Elliptic Laboratories's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Elliptic Laboratories AS over time as well as its relative position and ranking within its peers.
Elliptic |
Elliptic Laboratories Current Valuation vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Elliptic Laboratories's current stock value. Our valuation model uses many indicators to compare Elliptic Laboratories value to that of its competitors to determine the firm's financial worth. Elliptic Laboratories AS is rated as one of the top companies in revenue category among its peers. It also is rated as one of the top companies in current valuation category among its peers reporting about 36.62 of Current Valuation per Revenue. Comparative valuation analysis is a catch-all model that can be used if you cannot value Elliptic Laboratories by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Elliptic Laboratories' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Elliptic Revenue vs. Competition
Elliptic Laboratories AS is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Software—Application industry is currently estimated at about 908.46 Million. Elliptic Laboratories holds roughly 54.6 Million in revenue claiming about 6% of equities listed under Software—Application industry.
Elliptic Current Valuation vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Elliptic Laboratories |
| = | 54.6 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Elliptic Laboratories |
| = | 2 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Elliptic Current Valuation vs Competition
Elliptic Laboratories AS is rated as one of the top companies in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Software—Application industry is currently estimated at about 10.04 Billion. Elliptic Laboratories retains roughly 2 Billion in current valuation claiming about 20% of equities listed under Software—Application industry.
Elliptic Laboratories Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Elliptic Laboratories, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Elliptic Laboratories will eventually generate negative long term returns. The profitability progress is the general direction of Elliptic Laboratories' change in net profit over the period of time. It can combine multiple indicators of Elliptic Laboratories, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Elliptic Laboratories AS provides software-based artificial intelligence virtual smart sensors in Norway, China, South Korea, the United States, and Japan. The company was founded in 2006 and is based in Oslo, Norway. ELLIPTIC LABORATOR is traded on Oslo Stock Exchange in Norway.
Elliptic Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Elliptic Laboratories. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Elliptic Laboratories position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Elliptic Laboratories' important profitability drivers and their relationship over time.
Use Elliptic Laboratories in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elliptic Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elliptic Laboratories will appreciate offsetting losses from the drop in the long position's value.Elliptic Laboratories Pair Trading
Elliptic Laboratories AS Pair Trading Analysis
The ability to find closely correlated positions to Elliptic Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elliptic Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elliptic Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elliptic Laboratories AS to buy it.
The correlation of Elliptic Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elliptic Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elliptic Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elliptic Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Elliptic Laboratories position
In addition to having Elliptic Laboratories in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Healthcare theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Elliptic Stock
To fully project Elliptic Laboratories' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Elliptic Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Elliptic Laboratories' income statement, its balance sheet, and the statement of cash flows.